Xiaoying Chen: Rethinking Thrombectomy in Large-Core Stroke – Insights from LASTE Analysis
Xiaoying Chen, Senior Research Fellow at The George Institute for Global Health, shared on LinkedIn about a recent article by Bertrand Lapergue et al, published in Stroke, adding:
”One of the hardest questions in acute stroke is how far we can safely extend reperfusion treatment in patients with very large established infarcts.
This secondary analysis from LASTE suggests that even patients with ASPECTS 0–2 should not be treated as a uniformly futile group, with signals for better outcomes and lower mortality after thrombectomy.
From my perspective, this is exactly where modern stroke trials need to go next: not broad over-simplifications of ‘large core’ stroke, but smarter subgroup learning that can identify where benefit persists, where bleeding risk rises, and how more precise treatment decisions can be made in real-world practice.”
Title: Endovascular Thrombectomy in Patients With Largest Baseline Infarcts (ASPECTS 0–2): An Ancillary Analysis of the LASTE Trial
Authors: Bertrand Lapergue, Caroline Arquizan, J.F. Albucher, Christophe Cognard, Hilde Henon, Nasreddine Nouri, Benjamin Gory, Sebastien Richard, Gauthier Marnat, Igor Sibon, Federico Di Maria, Mariam Annan, Grégoire Boulouis, Pere Cardona, Julien Labreuche, Vincent Costalat, Tudor Jovin

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy